Form 8-K ARVINAS, INC. For: Jun 22

Go back to Form 8-K ARVINAS, INC. For: Jun 22

Arvinas CMO to depart in July as company begins search

June 22, 2026 4:13 PM EDT

Arvinas, Inc. (NASDAQ: ARVN) announced that Noah Berkowitz, M.D., Ph.D., the company's chief medical officer, will depart from his role effective July 3, 2026.

According to a press release statement, the company and Dr. Berkowitz agreed on June 22, 2026, that he would leave to... More